PITAVASTATIN CALCIUM (Livalo) Nursing Considerations

What is the generic name?

PITAVASTATIN CALCIUM

What is the Trade Name for PITAVASTATIN CALCIUM?

Livalo

What are the Indications for PITAVASTATIN CALCIUM?

• 1 INDICATIONS AND USAGE LIVALO is indicated as an adjunctive therapy to diet in: Adult patients with primary hyperlipidemia or mixed dyslipidemia to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C). Pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated TC, LDL-C, and Apo B. Limitations of Use The effect of LIVALO on cardiovascular morbidity and mortality has not been determined. LIVALO is a HMG-CoA reductase inhibitor indicated as an adjunctive therapy to diet in: Adult patients with primary hyperlipidemia or mixed dyslipidemia to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C) ( 1 ). Pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated TC, LDL-C, and Apo B ( 1 ). Limitations of Use: The effect of LIVALO on cardiovascular morbidity and mortality has not been determined.

References: https://open.fda.gov/